✦ LIBER ✦

Implications of Rosiglitazone and Pioglitazone on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

✍ Scribed by Dr. Brian K. Irons; Dr. Ronald Shane Greene; Dr. Timothy A. Mazzolini; Dr. Krystal L. Edwards; Dr. Rebecca B. Sleeper

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beneficial effects of rosiglitazone on n

✍ N. P. E. Kadoglou; F. Iliadis; N. Angelopoulou; D. Perrea; C. D. Liapis; M. Alev 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

Withdrawal of pioglitazone in patients w

✍ M. Iwase; T. Asano; N. Sasaki; H. Yoshizumi; S. Hiramatsu; Y. Sakai; A. Ogo; M. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Rosiglitazone and pioglitazone increase

✍ R. E. Aubert; V. Herrera; W. Chen; S. M. Haffner; M. Pendergrass 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

Metformin–pioglitazone and metformin–ros

✍ G. Derosa; A. D'Angelo; P. D. Ragonesi; L. Ciccarelli; M. N. Piccinni; F. Pricol 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Exercise training ameliorates the effect

✍ Nikolaos P.E. Kadoglou; Fotios Iliadis; Nikolaos Sailer; Zoi Athanasiadou; Iouli 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Pulse Pressure Predicts Cardiovascular R

✍ John R. Cockcroft; Ian B. Wilkinson; Marc Evans; Philip McEwan; John R. Peters; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB